PERSEGHIN GIANLUCA

Posizione organizzativa:

Ruolo:

Professore ordinario

Settore scientifico disciplinare:

ENDOCRINOLOGIA (MED/13)

Afferenza:

E-mail:

Corrao, G., Monzio Compagnoni, M., Ronco, R., Merlino, L., Ciardullo, S., Perseghin, G., et al. (2020). Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk?. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 478(5), 992-1003. Dettaglio
Ferrario, L., Schettini, F., Foglia, E., Avogaro, A., Bellia, C., Bertuzzi, F., et al. (2020). Pazienti diabetici di tipo 2, non in terapia insulinica e albumina glicata: UNA valutazione multidimensionale
Insuline-Naive type 2 diabetic patients: a multidimensional evaluation on the role of glycated albumin. BIOCHIMICA CLINICA, 44(1), 52-60. Dettaglio
Ciardullo, S., Muraca, E., Perra, S., Bianconi, E., Zerbini, F., Oltolini, A., et al. (2020). Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ OPEN DIABETES RESEARCH AND CARE, 8(1). Dettaglio
Castoldi, G., Carletti, R., Ippolito, S., Colzani, M., Barzaghi, F., Stella, A., et al. (2020). Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension. AMERICAN JOURNAL OF NEPHROLOGY, 51(2), 119-129. Dettaglio
Manzoni, G., Oltolini, A., Perra, S., Muraca, E., Ciardullo, S., Pizzi, M., et al. (2020). Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes. DIABETES, METABOLIC SYNDROME AND OBESITY, 13, 489-497. Dettaglio

Futuri studenti